171 related articles for article (PubMed ID: 37315401)
21. Expression of microRNAs of C19MC in Different Histological Types of Testicular Germ Cell Tumour.
Flor I; Spiekermann M; Löning T; Dieckmann KP; Belge G; Bullerdiek J
Cancer Genomics Proteomics; 2016; 13(4):281-9. PubMed ID: 27365378
[TBL] [Abstract][Full Text] [Related]
22. An Overview on Predictive Biomarkers of Testicular Germ Cell Tumors.
Chieffi P
J Cell Physiol; 2017 Feb; 232(2):276-280. PubMed ID: 27405110
[TBL] [Abstract][Full Text] [Related]
23. Clonal analyses of refractory testicular germ cell tumors.
Barrett MT; Lenkiewicz E; Malasi S; Stanton M; Slack J; Andrews P; Pagliaro L; Bryce AH
PLoS One; 2019; 14(3):e0213815. PubMed ID: 30870501
[TBL] [Abstract][Full Text] [Related]
24. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
[TBL] [Abstract][Full Text] [Related]
25. Germ cell tumour subtypes display differential expression of microRNA371a-3p.
Vilela-Salgueiro B; Barros-Silva D; Lobo J; Costa AL; Guimarães R; Cantante M; Lopes P; Braga I; Oliveira J; Henrique R; Jerónimo C
Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685967
[TBL] [Abstract][Full Text] [Related]
26. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up.
Chavarriaga J; Hamilton RJ
Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757
[TBL] [Abstract][Full Text] [Related]
27. Cancer Stem Cell Niche and Immune-Active Tumor Microenvironment in Testicular Germ Cell Tumors.
Kalavska K; Kucerova L; Schmidtova S; Chovanec M; Mego M
Adv Exp Med Biol; 2020; 1226():111-121. PubMed ID: 32030680
[TBL] [Abstract][Full Text] [Related]
28. Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA.
Tanaka K; Kondo K; Kitajima K; Muraoka M; Nozawa A; Hara T
J Biol Chem; 2013 Aug; 288(33):23990-9. PubMed ID: 23843459
[TBL] [Abstract][Full Text] [Related]
29. Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.
Carouge D; Blanc V; Knoblaugh SE; Hunter RJ; Davidson NO; Nadeau JH
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5425-33. PubMed ID: 27582469
[TBL] [Abstract][Full Text] [Related]
30. An oncofetal and developmental perspective on testicular germ cell cancer.
Rijlaarsdam MA; Looijenga LH
Semin Cancer Biol; 2014 Dec; 29():59-74. PubMed ID: 25066859
[TBL] [Abstract][Full Text] [Related]
31. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
AlDubayan SH; Pyle LC; Gamulin M; Kulis T; Moore ND; Taylor-Weiner A; Hamid AA; Reardon B; Wubbenhorst B; Godse R; Vaughn DJ; Jacobs LA; Meien S; Grgic M; Kastelan Z; Markt SC; Damrauer SM; Rader DJ; Kember RL; Loud JT; Kanetsky PA; Greene MH; Sweeney CJ; Kubisch C; Nathanson KL; Van Allen EM; Stewart DR; Lessel D;
JAMA Oncol; 2019 Apr; 5(4):514-522. PubMed ID: 30676620
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of microRNAs in testicular germ cell tumors: a systematic review and meta-analysis.
Zhao XY; Gao YL; Li DF; Liu HC; Zhu RF; Zhu CT
Aging (Albany NY); 2021 Aug; 13(15):19657-19677. PubMed ID: 34343969
[TBL] [Abstract][Full Text] [Related]
33. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.
Kalavska K; Conteduca V; De Giorgi U; Mego M
Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694
[TBL] [Abstract][Full Text] [Related]
34. Genetic aspects of testicular germ cell tumors.
Krausz C; Looijenga LH
Cell Cycle; 2008 Nov; 7(22):3519-24. PubMed ID: 19001860
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs for detecting occult genitourinary cancer.
Tavares NT; Lobo J; Bagrodia A
Curr Opin Urol; 2024 Jan; 34(1):20-26. PubMed ID: 37916954
[TBL] [Abstract][Full Text] [Related]
36. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
Cavallo F; Feldman DR; Barchi M
Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
[TBL] [Abstract][Full Text] [Related]
37. Molecular biology of testicular germ cell tumors.
Gonzalez-Exposito R; Merino M; Aguayo C
Clin Transl Oncol; 2016 Jun; 18(6):550-6. PubMed ID: 26482724
[TBL] [Abstract][Full Text] [Related]
38. Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors.
Thomas JP; Davis-Dao C; Lewinger JP; Siegmund KD; Hamilton AS; Daneshmand S; Skinner EC; Thomas DC; Cortessis VK
Am J Epidemiol; 2013 Oct; 178(8):1240-5. PubMed ID: 23928263
[TBL] [Abstract][Full Text] [Related]
39. The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.
Li Y; Tabatabai ZL; Lee TL; Hatakeyama S; Ohyama C; Chan WY; Looijenga LH; Lau YF
Hum Pathol; 2007 Oct; 38(10):1470-81. PubMed ID: 17521702
[TBL] [Abstract][Full Text] [Related]
40. Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors.
Özata DM; Li X; Lee L; Liu J; Warsito D; Hajeri P; Hultman I; Fotouhi O; Marklund S; Ährlund-Richter L; Juhlin CC; Larsson C; Lui WO
Cell Death Dis; 2017 May; 8(5):e2759. PubMed ID: 28471449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
